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Abstract: Given research showing that the very act of communicating side effects can increase their
likelihood, how can providers inform patients about side effects while upholding their oath to do no
unnecessary harm? An emerging approach provides a potential solution: truthfully describe certain
minor side effects as a sign the treatment is active and working in the body. This approach focuses on
instilling adaptive mindsets about the meaning of side effects while still keeping patients informed. This
article describes existing research suggesting that this approach can be helpful in improving experience
and outcomes in treatments for pain, hypertension and allergy. Compared with control groups given a
standard, empathetic message about side effects, patients who were informed that side effects are a sign
treatment is working were less anxious about side effects and rated them as less threatening and intense.
A longitudinal, randomised controlled trial of this approach in patients receiving oral immunotherapy for
food allergies found that describing side effects as a sign treatment was working reduced the rate at which
patients contacted providers with concerns about side effects and led to greater increases in a biomarker
of allergic tolerance from pretreatment to post-treatment (peanut-specific blood IgG4). In unveiling
this approach, this article also raises important issues regarding which treatments and symptoms this
approach should be applied to. Finally, we outline questions future research should address to further
understand and leverage this approach.
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ABSTRACT
Given research showing that the very act of 
communicating side effects can increase their likelihood, 
how can providers inform patients about side effects 
while upholding their oath to do no unnecessary harm? An 
emerging approach provides a potential solution: truthfully 
describe certain minor side effects as a sign the treatment 
is active and working in the body. This approach focuses 
on instilling adaptive mindsets about the meaning of side 
effects while still keeping patients informed. This article 
describes existing research suggesting that this approach 
can be helpful in improving experience and outcomes in 
treatments for pain, hypertension and allergy. Compared 
with control groups given a standard, empathetic message 
about side effects, patients who were informed that side 
effects are a sign treatment is working were less anxious 
about side effects and rated them as less threatening and 
intense. A longitudinal, randomised controlled trial of this 
approach in patients receiving oral immunotherapy for 
food allergies found that describing side effects as a sign 
treatment was working reduced the rate at which patients 
contacted providers with concerns about side effects and 
led to greater increases in a biomarker of allergic tolerance 
from pretreatment to post- treatment (peanut- specific 
blood IgG4). In unveiling this approach, this article also 
raises important issues regarding which treatments and 
symptoms this approach should be applied to. Finally, we 
outline questions future research should address to further 
understand and leverage this approach.
CHANGING MINDSETS ABOUT SIDE EFFECTS
Describing certain minor side effects as a 
sign that treatment is active and working can 
improve treatment experience while keeping 
patients fully informed about potential side 
effects.
Providers are ethically obligated to inform 
patients about possible treatment side effects. 
Yet the very act of communicating side effects 
can increase their likelihood.1–4 For example, 
compared with men who were not informed, 
men receiving a medication for prostate 
gland enlargement reported a 28.3% increase 
in sexual dysfunction when informed it was a 
side effect.2 Similarly, patients receiving treat-
ment for unstable angina pectoris informed 
of possible gastrointestinal side effects were 
six times more likely than patients who had 
not been informed to stop treatment due to 
these side effects.4
A recent review assessed 27 studies that 
attempted to inform patients about side 
effects without increasing their likelihood 
and found that the most effective intervention 
was to refrain from disclosing side effects.5 
But withholding side effect information from 
patients is problematic. Patients need to be 
informed of possible side effects so they can 
make educated decisions about treatment 
and know when to seek medical help. With-
holding side effect information may also 
undermine trust in patient–provider relation-
ships, thereby worsening health outcomes 
over time. This puts healthcare providers in 
a difficult position. How can providers fully 
inform patients while upholding their oath to 
do no unnecessary harm?
RETHINKING SIDE EFFECTS
An emerging approach attempts to achieve 
both goals: truthfully describe certain minor 
side effects as a sign the treatment is active 
and working in the body.6–8 This approach is 
more nuanced than simply deciding which 
side effects to disclose to patients. Instead, 
it focuses on instilling adaptive mindsets 
about the meaning of side effects while still 
informing patients about them.
To understand this approach, it is first 
helpful to think through the mindset patients 
typically have about side effects. At best, 
patients may assume that side effects are 
unfortunate or harmful byproducts of treat-
ment. At worst, patients may assume that side 
effects are a sign that the treatment is not 
working, that their body is particularly sensi-
tive to medication or that their own condition 
is treatment resistant.
These negative assumptions overlook a 
more encouraging truth about side effects: for 
many conditions and treatments, side effects 
can indicate that the treatment is active and 
working in the body.8–10 Take vaccinations for 
example: vaccinations work by activating the 
body’s immune response, which helps the 
body remember a particular virus in case it 
ever invades the body again. As a result, most 
side effects from vaccinations are a signal that 
the body is starting to build up the immune 
system so that it can tolerate the virus in case 
of future infection.11 12 Similarly, during oral 
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immunotherapy for food allergies, patients may have mild 
side effects (eg, itchy mouth, nausea) when consuming 
their doses. However, patients may not realise that these 
mild side effects can indicate that the body is building 
allergen desensitisation.8 Another good example is anti-
biotics: when antibiotics effectively kill harmful bacteria 
in the body, they also frequently kill helpful bacteria in 
the intestine, resulting in unpleasant, but usually not 
dangerous, side effects, such as diarrhoea.13 These side 
effects can thus signal that the antibiotics are working. 
Similarly, chemotherapy works by killing fast- growing 
cancer cells, but can also kill fast- growing healthy cells, 
such as hair follicles and cells in the digestive track.14 This 
can lead to common side effects, such as hair loss and 
nausea, that are emotionally intense but also signs that 
the treatment is active in the body.
The ways providers communicate about side effects 
play an important role in shaping patients’ mindsets 
about them.15 16 In many cases, patients may view side 
effects as wholly negative, even when there is evidence 
to support otherwise. Even well- intentioned efforts to 
inform patients and empathise with them about side 
effects may inadvertently serve to instil and reinforce the 
mindset that side effects are wholly negative. By being 
mindful when describing side effects, providers can help 
patients rethink their meaning. Describing minor, non- 
life- threatening side effects as a sign the treatment is 
working can instil the mindset that, although they may 
be uncomfortable, these side effects indicate treatment 
progress.
STATE OF THE SCIENCE
To date, three studies have empirically tested the 
approach of describing side effects as a sign that treat-
ment is working (table 1). Results from these studies 
suggest that this approach significantly improves patient’s 
experience during treatment. Compared with control 
groups given a standard, empathetic message about side 
effects, patients who were informed that side effects are 
a sign treatment is working were less anxious about side 
effects8 and rated side effects as less threatening6 and 
less intense.7 Reducing threat, worry and intensity of side 
effects are powerful ways to improve overall treatment 
experience.
There is also evidence that this approach can reduce 
the number of questions providers receive about side 
effects. One longitudinal randomised controlled trial 
examined the influence of mindset about side effects on 
children/adolescents undergoing oral immunotherapy 
for peanut allergies. This study found that during the 
6- month treatment, describing side effects as a sign treat-
ment was working reduced the rate at which patients 
contacted providers with concerns about side effects.8 
This outcome is especially encouraging given the many 
demands on providers’ time and the costs associated with 
answering patients’ questions outside of office visits.
This approach may also increase treatment efficacy. The 
study of children/adolescents undergoing oral immuno-
therapy found that patients informed that side effects were 
a sign the treatment was working had greater increases in 
a biomarker of allergic tolerance from pretreatment to 
post- treatment (peanut- specific blood IgG4).8 Likewise, 
Fernandez et al found that, for participants informed that 
side effects were a sign an analgesic was working, expe-
riencing side effects was associated with increased anal-
gesic efficacy, with these participants reporting a greater 
increase in pain reduction.7 These findings align with 
other research demonstrating that the presence of side 
effects can increase a treatment’s effectiveness, in part 
by strengthening beliefs that the treatment is working.9 
Research on fear avoidance of bodily symptoms also 
supports these findings: changing patients’ perceptions 
of side effects’ threateningness can impact their occur-
rence, intensity and unpleasantness.17
How does this approach influence overall side effect 
occurrence? Two of the studies found that groups that 
were informed that side effects were a sign the treatment 
was working experienced a similar number of side effects 
as control groups.6 7 Yet these participants rated their side 
effects as less threatening and intense, suggesting that it is 
possible to improve the experience of side effects without 
reducing their occurrence. Another study found that this 
approach reduced side effects at the highest treatment 
doses (there was no difference between groups at low 
doses)8 (table 1). Future studies should continue to assess 
how this approach influences side effect occurrence and 
reporting.
Importantly, evidence also suggests that participants 
preferred this approach. At the end of their study, 
Fernandez et al exposed all participants to both a stan-
dard side effects description and the description of side 
effects as a sign the treatment is working. Overall, 65% 
of participants preferred the latter.7 This suggests that, 
when given an informed choice, most people prefer to 
have side effects explained as an indication of treatment 
efficacy.
ETHICALLY APPLYING THIS APPROACH
Key considerations
This approach to discussing side effects should not be 
applied universally. Several key issues must be considered 
in order to achieve the ultimate goals of informing the 
patient and doing no harm. Most importantly, the infor-
mation about side effects should be true and supported 
by mechanistic evidence suggesting that the side effects 
mean the treatment is active and working in the body. 
Providers should never misinform patients about a partic-
ular treatment or associated side effect. Fortunately, there 
are many cases in which these links are well documented, 
as previously described in the cases of vaccinations, 
immunotherapy, antibiotics and chemotherapy. Future 
research may continue to shed light on cases where side 
effects are linked with treatment efficacy.
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Many drugs and treatments have a range of side effects, 
some of which are severe and require medical atten-
tion and some of which are more minor. This approach 
should only be applied to minor, non- life- threatening 
symptoms that may be uncomfortable, but are likely to 
be resolved without medical attention (eg, mild head-
aches, dizziness or nausea). Providers should never mini-
mise harmful or life- threatening side effects, as they are 
an important factor in making the decision to undergo 
treatment. It is critical that providers distinguish which 
side effects necessitate medical action, as in previous clin-
ical research on this approach: the longitudinal study of 
this strategy in oral immunotherapy clearly distinguished 
between minor, non- life- threatening side effects that 
signalled treatment efficacy and the few, rare side effects 
that required medical intervention.8 Only after such a 
distinction can providers safely describe minor, non- life- 
threatening side effects as a sign treatment is working. This 
strategy can help patients understand which side effects 
are serious while changing the meaning of common, non- 
serious side effects that frequently interfere with adher-
ence to safe and effective treatments. Which side effects 
can be appropriately described as signals of treatment 
efficacy will vary by condition, treatment and patient. As 
with other health messaging and treatments themselves, 
providers and care teams must decide on a case- by- case 
basis whether side effects can be described as a sign the 
treatment is working.
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‘If you do experience 
a side effect, you 
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analgesic medication 
is active in your 
body…this is a signal 









caused by the 
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undergoing a 6- month 
oral immunotherapy 
treatment for peanut 
allergies
‘Side effects mean 
that the treatment 
is working and your 
body is getting 
stronger and building 
tolerance to peanuts’.
Communicated and 
reinforced in various 
ways over a 6- month 
course of treatment




effects at high 
treatment dose
Less anxious about 
side effects, less 
likely to report 
dosing had not 
gone well when 
experiencing side 
effects and less 
likely to contact 
staff with concerns 
about side effects
Marginally less 
likely to skip or 
reduce doses 
due to treatment 
anxiety
Greater increase in 




80 healthy male 
participants between 
ages 18 and 35 
given a hypertensive 
medication 
(metoprolol)
‘Dizziness is a sign 
that the drug is 
starting to work. 
If you become 
dizzy after taking 
the medication, it 
means that your 
body is responding 




No difference Side effects 
experienced as 
less threatening 
and less likely to 
view side effects as 
an adverse effect of 
medication
N/A N/A
*In all three studies, participants were randomised to either be informed that side effects were a sign the treatment was active/working 
or to receive a standard description of side effects. The standard description informed patients about potential side effects and provided 
sympathetic statements like ‘we will do our best to ensure your comfort’.
†Results depict the effect of describing side effects as a sign the treatment is active/working as compared with the condition that received 
the standard description.
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A final, more nuanced, concern is to consider how 
patients may respond to this mindset in the cases when 
they do not experience symptoms. If patients are told 
that side effects mean the treatment is working, they may 
interpret a lack of side effects as a sign that the treatment 
is not working. Even while describing side effects as a 
sign treatment is working, providers can be clear that a 
lack of side effects is not indicative of treatment failure. 
Since the typical patient’s mindset may be that ‘no side 
effects is good news’, patients will likely recognise a lack 
of symptoms as a sign the treatment is going well. This 
is supported by the research on this approach. In the 
clinical, longitudinal study, patients who remained side 
effect- free believed that treatment was working just as well 
for them as patients who experienced side effects.8 This 
suggests that even when side effects are given a positive 
meaning, a lack of side effects is not necessarily viewed as 
problematic or undesirable.
Future research and fertile ground
Changing patients’ mindsets so that they view minor side 
effects as signs that the treatment is working, rather than 
worrisome indicators that the treatment is ineffective or 
harmful, can improve patients’ experience and outcomes 
while still keeping patients informed. Evidence in favour 
of this approach for certain symptoms and conditions is 
promising, but in its early stages, and more research is 
needed to effectively understand and leverage it.
To support this approach, further efforts are needed 
to understand the complex relationship between side 
effects and drug mechanisms. As part of drug trials, drug 
manufacturers should be asked to not only to measure 
and document the potential side effects associated with 
treatments, but also to describe how the side effects may 
relate to the mechanisms of treatment efficacy.
Research is also needed on best practices for commu-
nicating information about the meaning, probability 
and frequency of side effects. Other strategies have been 
suggested for communicating side effect frequency,18 and 
future research is needed to understand how describing 
side effects as signs of treatment efficacy interacts with 
other messaging strategies aimed to reduce side effects. 
For example, several studies have found that positive 
framing may reduce side effects. Positive framing refers 
to sharing information on number of people who do not 
experience side effects as opposed to sharing the number 
of people who do (eg, ‘95% of patients do not experience 
side effects of headache or dizziness’ vs ‘5% of patients 
experience headache or dizziness’).19 Future studies 
might test a strategy of emphasising the number of people 
who do not experience side effects and highlighting 
that, in the unlikely event a patient does experience 
side effects, these side effects are a sign the treatment is 
working. These studies could help us understand whether 
a multitiered message is more effective than using either 
strategy alone.
The studies reviewed here communicated the message 
that side effects signal treatment efficacy in a number of 
different ways, including a brief face- to- face interaction, 
a video message and an intensive 6- month intervention. 
Future research should explore how different vehicles for 
communicating information regarding side effects, such 
as government websites, advertising and the media, influ-
ence patients’ mindsets about side effects for better or for 
worse.20
This approach provides fertile ground for exploring 
other ways in which this mindset may be useful. For 
example, explaining side effects as a sign that treatment 
is working may be particularly helpful for certain treat-
ments, such as antidepressants, where side effects may 
precede healing by weeks or months. Describing side 
effects as a sign that these treatments are working may 
give patients hope and motivation to persevere until 
treatment takes effect. Relatedly, this approach may help 
when necessary medications provide little symptomatic 
relief, such as in hypertension.21 Since hypertension is 
often asymptomatic, side effects may make patients feel 
worse than they did without medication. In these cases, 
reassuring patients that minor side effects are a positive 
sign that treatment is working may help patients recog-
nise medications’ benefits. Indeed, minor side effects can 
produce anxiety and worry that is disproportionate to 
patients’ physical symptoms. This is one reason patients 
often come to the doctor’s office primarily seeking 
reassurance.22 By anticipating and addressing patients’ 
(conscious or unconscious) fears that side effects indicate 
the treatment is not going well, this approach can reduce 
treatment- related anxiety6 8 and may motivate patients to 
stick with treatment despite side effects.10
This approach may also be useful for shaping patient’s 
mindsets about symptoms that do not require medical 
treatment, such as those associated with colds and other 
viruses. While patients might not be aware of this, uncom-
fortable symptoms can be a natural part of the healing 
process.23 Fevers and associated achiness and chills are 
a sign the body is fighting infection.24 Likewise, wound 
inflammation is indicative of a healing response in 
which enzymes and histamines are released.25 Informing 
patients that certain minor symptoms are part of the 
body’s natural healing processes may reduce demands 
for unnecessary medications, such as antibiotics for colds, 
while also reassuring patients when these symptoms are 
not dangerous. While these areas represent particularly 
viable options for additional research, future studies can 
help us broadly understand what patients, situations and 
treatments this approach is most beneficial for.
Leveraging mindset: a useful tool for physicians more broadly
How to disclose side effects without increasing their likeli-
hood has been a problem for decades. Yet relatively little 
progress has been made addressing it. Describing minor 
side effects as a sign the treatment is active and working 
is a promising strategy for more fully informing patients 
about potential side effects without causing unnecessary 
harm. Importantly, this potential solution highlights 
how providers’ ability to shape patients’ mindsets during 
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treatment can be fruitfully applied to improve healthcare. 
Rethinking how providers inform patients about side 
effects is just one of the many possible opportunities to 
instil beneficial mindsets in the clinical encounter.
Twitter Kari A Leibowitz @karismatically, Lauren C Howe @howelaurenc and Alia J 
Crum @AliaCrum
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